Atropine sulfate 0.025% eye drops not checked

IDB VisionCare SDN BHD

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
Anticholinergic; Cholinergic Muscarinic Antagonist FDA class
Tested for
Myopia Progression
Main trialPhase 3
“This clinical trial is designed to assess the efficacy and safety of Atropine Sulphate 0.025% w/v Eye Drops compared to placebo in a randomized, double-blind, placebo-controlled study for the management of myopia progression in children.”In the company’s words, NCT07329777 on ClinicalTrials.gov
Other names
Low dose atropine sulfate eye drops

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Sep 2027 Atropine in the Treatment of Myopia Study in Malaysia
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Atropine sulfate 0.025% eye drops

Following is part of Solo: you see every change to Atropine sulfate 0.025% eye drops the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in